GLP-1 receptor agonists in obesity-related knee osteoarthritis: from weight loss to therapeutic pathway reconstruction.

Wu J, Lei Y, Sa R, Zhong Y, Lu Y

Open source

DOI
10.3389/fphar.2026.1856307
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1856307,
  title = {GLP-1 receptor agonists in obesity-related knee osteoarthritis: from weight loss to therapeutic pathway reconstruction.},
  author = {Wu J and Lei Y and Sa R and Zhong Y and Lu Y},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1856307},
  url = {https://doi.org/10.3389/fphar.2026.1856307}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists in obesity-related knee osteoarthritis: from weight loss to therapeutic pathway reconstruction.
AU  - Wu J
AU  - Lei Y
AU  - Sa R
AU  - Zhong Y
AU  - Lu Y
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1856307
UR  - https://doi.org/10.3389/fphar.2026.1856307
ER  - 

APA

J, W., Y, L., R, S., Y, Z., & Y, L. (2026). GLP-1 receptor agonists in obesity-related knee osteoarthritis: from weight loss to therapeutic pathway reconstruction.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1856307

Source records